Good day, and welcome to the Alto Ingredients First Quarter 2023 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Kirsten Chapman, LHA Investor Relations. Please go ahead.

Thank you, Betsy, and thank you all for joining us today for the Alto Ingredients' first quarter 2023 results conference call. On the call today are Mike Kandris, CEO; and Bryon McGregor, CFO. Alto Ingredients issued a press release after the market closed today providing details on the Company's financial results. The Company is also prepared a presentation for today's call that is available on the Company's website at altoingredients.com. A telephone replay of today's call will be available through May 15, the details of which are included in today's press release. A webcast replay will be available on the website as well. Please note that the information on this call speaks as of today, May 8. You're advised that any time-sensitive information may no longer be accurate at a time of any replay. Please refer to the Company's Safe Harbor statement on Slide 2 of the presentation available online, which states that some of the comments in the presentation constitute forward-looking statements and considerations that involve a number of risks and uncertainties. The actual future results of Alto Ingredients could differ materially from those statements. Factors that could cause or contribute to such differences include, but are not limited to, events, risks and other factors, previously and from time to time disclosed in Alto Ingredients' filings with the SEC. Except as required by applicable law, the Company assumes no obligation to update any forward-looking statements. In management's prepared remarks, non-GAAP measures will be referenced. Management uses these non-GAAP measures to monitor the financial performance of the operations and believe these measures will assist investors in assessing the Company's performance for the periods being reported. The Company defines adjusted EBITDA as unaudited net income or loss before interest expense, interest income, provision for income taxes, asset impairments loss of extinguishment of debt, acquisition-related expense, fair value adjustments, and depreciation and amortization expense. To support the Company's review of any non-GAAP information, a reconciling table was included in today's press release. On the call today are – Mike will provide a review of the strategic plan and activities. Bryon will comment on our financial results. Then Mike will wrap up and open the call for questions. It's now my pleasure to introduce Mike Kandris, CEO. Please go ahead, sir.

Thank you, Kirsten, and thank you, everyone, for joining us today to review the first quarter of 2023. Since our call in March, we have continued to make good progress on our transformative capital projects, which will drive our near and long-term EBITDA expansion goals. I will discuss this further in a minute. We are also pleased with the current market improvements, which are positively impacting our business. Crush margins have been improving since December. Notably, each month this year has improved sequentially. March 2023 ended with regional natural gas prices, corn basis and ethanol prices greatly improved over December of 2022, all of which benefited our business. For the month of March, we generated positive bottom line financial results. Should the strong crush margins continue, we would expect positive adjusted EBITDA for the second quarter of 2023. Bryon will review the financial results in detail shortly. Even though we have positive crush margins today, we don't control commodity pricing. This is exactly why we are implementing a series of near and long-term projects aimed at reducing our exposure to those volatile markets. We continue to transform Alto Ingredients by further diversifying our products and optimizing operations to expand margins and increase profitability. We are excited about our capital improvement initiatives and their return profiles. With the completion of our near-term projects, we expect to increase annualized EBITDA by over $65 million by the end of 2025, an increase to $125 million annually by the end of 2026, when our carbon capture and sequestration, cogeneration and other initiatives are fully realized. Regarding diversification, our strategy is to pursue multiple paths. We are increasing production of our most differentiated and highest quality products. Our near-term focus includes grain neutral spirits, corn oil and high protein, and our longer-term plan includes primary…

Thank you, Mike. I'll provide additional color around our first quarter 2023 results. I'd like to reemphasize that our business can be impacted by seasonal swings in consumer demand. For instance, reductions in ethanol usage during the fourth and first quarters or winter period [immediately impacted] margins. With increased driving activity in spring and summer periods, it is normal demand for ethanol increase and margins improvement. Therefore, the simple annualization of a quarter will not provide an accurate projection for [indiscernible]. While January proved challenging, but better than December, we benefited from significant sequential ethanol margin improvement in February and March. As a result, our Q1 2023 gross loss of $3 million improved greatly over Q4 2022. For Q1 2023, that loss available to common stockholders was $13.5 million, and adjusted EBITDA was negative $4.5 million. In Q2 2023, with a continued improvement in margins to date and, as Mike mentioned, assuming they remain strong, we can expect to generate positive adjusted EBITDA. In addition, the renewable fuel outlook is improved as E15 was recently approved by the EPA for summer blending. Our cash balance was $21.2 million at the end of March compared to $36.5 million at the end of 2022. The change in cash represents $10 million invested in our projects, $3.5 million for crude to Eagle earnout payments and $1.7 million for 860,000 shares. Given Alto's significantly undervalued market price, these repurchases as a beneficial return on investment and effective use of current capital resources. Our liquidity remains strong and more than sufficient for our immediate needs. Our March 31 working capital was $118 million compared to $121 million at December 31, 2022. We have $40 million in unutilized committed borrowing and $25 million in uncommitted funds under our term loan facility to support our immediate capital improvement plans. In aggregate, these resources represent more than $180 million to support our business operations and [indiscernible]. While we have no intention of conducting an equity raise currently or at these irrational prices, our shelf expires this summer, and as part of good long-term financial planning, we intend to refresh it. While it is difficult to provide guidance for the full-year of 2023, we expect to benefit from approximately $10 million of EBITDA generated from the capital projects we have already completed or will complete this year. In addition, from our term loan and the associated accelerated investment in the further diversification of our specialty alcohols and essential ingredient products, as previously stated, we expect to almost double our annualized EBITDA by year-end 2025 compared to our average EBITDA over the past three years and nearly double it again when our other projects are fully operational by year-end 2026. We look forward over the coming quarters to discuss the progress we've made. With that, I'll turn the call back to Mike.

Thanks, Bryon. In summary, we are excited about our revenue specific plans, margin expansion, and plant optimization initiatives. We are executing as planned and pleased with our progress, particularly in the first quarter. Further, the increasingly positive renewable ethanol crush margins are encouraging. We are optimistic and expect positive adjusted EBITDA [indiscernible] based on current crush margins. Regarding our near-term projects, which we expect will achieve roughly $65 million of additional annualized EBITDA by the end of 2025 and with our longer-term initiatives, including CCS and cogeneration, we expect to increase annualized EBITDA to approximately $125 million by the end of 2026. We look forward to sharing our progress. With that, I'd like to open the call for questions. Operator?

We will now begin the question-and-answer session. [Operator Instructions] The first question today comes from Amit Dayal with H.C. Wainwright. Please go ahead.

Thank you. Good afternoon, everyone. Just quickly, guys, on the 2Q outlook with respect to the positive margins you're seeing, are you expecting net profit for the quarter or positive adjusted EBITDA for the quarter?

Good question, Amit. Right now, we're comfortable with the positive EBITDA. Our hope is to also be able to generate positive net [indiscernible], but it's still very early still. I know we used to give a longer guidance, but it's a world with lots of facts that continue to change. So we're comfortable with a positive EBITDA numbers right now, at least.

Understood. No, I appreciate that. Thank you. And then our specialty alcohol sales at this point, mostly in the spot market, Bryon, or is there any contracted volume that is also coming into play for you?

So as we mentioned last quarter, we entered the year with about $90 million of value – or 90 million gallons of contracted volume. The comments that Mike made with regards to gallons sold in the spot market represents the highest quality, the 190 proof or 200 proof, the dry product that's coming off of the improvements that we have completed in the first quarter of this year.

Yes, I could put a lot more – or a little more clear about that. That was really referring to – we missed the contracting cycle on GNS coming out of 2022. And so now that the system is up and running and producing wonderful. We are looking at the spot market for the remainder of this year, but fully again to hit the contracting cycle for 2024 when we get to the fall.

Understood. And just one last one for me. This EBITDA improvement you're expecting in 2023, has any of that materialized in 1Q? Or are we expecting those to come through in the second half of the year?

Oh, you mean of the $10 million that I mentioned previously?

Yes, yes.

Yes, I think of it as being spread out over the year. So yes, we're experiencing some of that. Some of that was not – so you'll recall, when we did the $10 million earlier in the quarter that we included – it assumed, we're restarting the Magic Valley facility in Q1. So we're still comfortable with those numbers and – but I would expect the balance of those to show up in the second half of the year.

Okay. Thank you, guys. That's all I have.

Thank you.

The next question comes from Eric Stine with Craig Hallum. Please go ahead.

Hi, Mike. Hi, Bryon.

Hi, Eric.

Hi, Eric.

So can I just confirm, just to follow-up on the previous question, so you talked about the $10 million in incremental, I guess, second half of 2023, and it might have been your phone or my phone, but it kind of cut out talking about – I'm not sure if you were talking about potentially how you see this rolling out 2024 and then into 2025 and I guess $65 million, approximately $65 million incremental at that point. The way it sounded to me, and again, I just want to confirm this, that your typical three-year average EBITDA has been about $30 million. Are you anticipating that you would double that, and that's kind of a soft outlook for 2024?

So the way that we've been talking about this is that these projects are going to be adding incremental benefits, right, to whatever we would be producing on a run rate basis. So if $30 million is a good base assumption, right, which includes both a good – some really good quarters and some really bad quarters, yes, then it would be incrementally on top of that. So you'd be assuming that you're on run rate for $30 million this year, you're adding an additional $4 million or $10 million on that, so you'd be at $40 million, and then you have incremental additions in 2024 on top of that, which would include gallons sold and GNS products sold for a full-year. So you get the benefit to that. We would expect as well to see full run rates for the Magic Valley facilities. And then incrementally, over time, you'd be adding additional corn oil capacity and rolling out, as Mike mentioned, is kind of a staggered rollout of the protein and corn oil projects, in addition to them rolling out renewable natural gas, the [indiscernible] pipeline benefits – sorry, yeast, and then, of course, in the bigger cogeneration and carbon sequestration. Included in that $10 million, of course, is the benefits and the savings that we get from now having corn oil – I'm sorry, from having corn storage, additional corn storage at the facility.

Yes. Okay. Got it. All right. So it sounds like that, I guess I did understand that correctly. So that's great. Maybe just turning to Magic Valley, I mean can you just talk about kind of the process that you've completed it? I mean how do you anticipate that rolling out? Is it a general ramp-up and something where you've got to bring it up, bring it back down, make sure it's running correctly? Or do you anticipate that it's more of a smooth linear ramp-up? And then maybe just some thoughts on what type of yields you're expecting either early on or as it plays out a little longer term?

Yes. So the plant is back up, and this is a fully integrated system within the plant. It's not just a bolt-on to the outside. So what we're doing right now, Eric, is we're fine-tuning all the different controls and mechanisms to make sure that the operators are trained, make sure everybody is up to speed. We have harvest technology on site, and we're dialing in with this system. We expect to have that within weeks dialed in and operating. And then you go through a process on the high protein. We've already worked with several of the people in the surrounding area in terms of acceptance of the protein product, which as we indicated, is over 50% and we expect to continue that sampling and working with various folks in the area to get that product placed. So it will be a little bit of a ramp-up as we go forward. But we fully expect by the end of this quarter will be – the system will be up and running, producing the product. Corn oil, by the way, should come up right away. There's such a strong demand for corn oil that soon as the system is fully up and running, we don't anticipate happy to do a lot of work to grow that market. So it's mainly on the protein side. Again, it will be a ramp-up through Q3, and then we expect it to be fully integrated for Q4 and beyond.

Got it. Okay. And maybe last one for me. Just on the carbon capture, I know that when you look out to 2026, you're targeting $30 million plus in incremental. And I know that's after, obviously, a lot of the cost. Does that contemplate having a partner where you're potentially splitting the economics? Or would that be a number that it's – that's kind of all-in number for you?

It's a great question, Eric. It could, but it may not require it as well. We're exploring all the various options. We're certainly in discussions with key relationships talking about that, seeing the best way to optimize the value for shareholders and for the company, right? So that's part of the negotiations and discussions, both with the downstream parties, right, as well as independent parties and then talking with other – and there's crossover as well as you start thinking about the environmental attributes associated with that. So there's a lot of demand for that product. And so part of the discussion is, of course, is lining that out and making sure that you have a good source of long-time customers that want that product. So it's a fairly complex and fully nuanced opportunity, but clearly a significant one. And there's a lot of attention and a lot of resources committed to this at this point.

Yes. And I guess that's why it would be 2026. Okay. I think that's it for me. Thank you.

Thanks, Eric.

[Operator Instructions] The next question comes from David Bastian with Kingdom Capital Advisors. Please go ahead.

Hey guys. Thanks for taking my question. First, I was wondering about the essential ingredient margins this quarter. It seemed like you guys got really good realizations there. I was curious what the key drivers were of that number being up?

Yes. Actually, I think part of that, David, is that we've – it's clearly a big driver for us in that essential ingredients market is how well the wet mill is operating. So we saw really good results. We've been able to get yields up. If you go back over the last couple of years, we've had – we've changed our flag, better term, our cocktail, the enzymes and the requirements to meet certain requirements, whether it's at the wet mill or at the ICP distillery, to be able to accommodate certain customers and the like, but that has not allowed us to get the yield that we otherwise would like. So we've made some changes to that, and we're seeing a lot better yield out of that. So we've also had better alignment of our drivers to be able to maximize the value of our various essential ingredients, almost had to put $1 in the swear jar there. But getting a lot better value for those various corn values that you get out of the wet mill as well. Mike, anything else that you think...

No. I mean, David, that's an absolute critical path for us to take the – with the wet mill, you have to get the value out of the essential ingredients. And as Bryon mentioned, we've made great progress in that regard.

Got it. Thanks. That's helpful. Question on the liquidity. You mentioned the remaining draws on your term loan. I didn't see the Kinergy line of credit listed with your liquidity levers. Is there a reason for that?

No. I think we tried to capture that in the prepared remarks. So that would be – the assumption is – well, first off, on the balance sheet that the Kinergy line shows up under the long-term debt. What we did mention was that we have excess of $40 million in availability as of the month end of the quarter or into Q1. Yes. And so that was a $40 million plus the $40 million that's available for – $40 million. So $40 million plus the additional $40 million that's available that's committed under the Orion facility plus an additional $25 million that's uncommitted, but available, and then any improvements in operating income and improvements in the working capital availability. That gets you to the $180 million.

Okay. And then on the working capital side, you listed that as a source of liquidity. How much do you think reasonably you'd be able to draw down on working capital, if needed?

Yes. So another way to think about it is the working capital reflects – it's another way to – how do I put this? It's a different perspective on the same question that you had before, which is how much excess availability, right? But for the fact that you only get certain advance rates under the line of credit from Wells Fargo, so you may – that difference is really just the amount of additional collateral they want on top of their existing borrowing base and excess availability. Does that make sense?

Got it. Okay. Thank you. That's all for me. Thanks.

Thanks, David.

This concludes our question-and-answer session. I would like to turn the conference back over to Mike Kandris for any closing remarks.

Thank you again for joining us today and for your continued support. We'll be in New York City conducting a non-deal roadshow with H.C. Wainwright later this month. Please let your Investor Relations team know if you would like to arrange a meeting. And with that, I'd like everyone to have a good day. Thank you.

The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.